OPKO HEALTH, INC. (OPK)
OPKO HEALTH, INC. (OPK) from its SEC filings: 2025 revenue $606.9 million (-15% vs the year before), net margin -37187%, free cash flow -$178.5 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Revenue (2025) | $606.9 million |
| Revenue growth | -15% |
| Net income | -$225.7 billion |
| Net margin | -37187.0% |
| Free cash flow | -$178.5 million |
| Diluted EPS | $-0.30 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +4% |
| Cash | $300.8 million |
| Long-term debt | $1.8 million |
| Share count, 1 year | -6% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.